tumor antigen pulsed DC autologous cellular vaccine (personalized cellular vaccine)
/ Guangzhou Trinomab Biotechnology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 27, 2022
Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)
(clinicaltrials.gov)
- P1 | N=10 | Completed | Sponsor: Guangdong 999 Brain Hospital | Active, not recruiting ➔ Completed
Trial completion • Brain Cancer • Oncology • Solid Tumor • CD4
1 to 1
Of
1
Go to page
1